Financial statements Andora-Pharm W Likwidacji
Balance sheet data of ANDORA-PHARM W LIKWIDACJI
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 135 413,52 | 164 858,84 | 264 699,53 | 288 944,11 | 401 120,25 | 348 416,83 |
| A. Fixed assets | 16 300,00 | 8 100,00 | 8 000,00 | 8 000,00 | 8 000,00 | 8 000,00 |
| B. Current assets | 119 113,52 | 156 758,84 | 256 699,53 | 280 944,11 | 393 120,25 | 340 416,83 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 135 413,52 | 164 858,84 | 264 699,53 | 288 944,11 | 401 120,25 | 348 416,83 |
| A. Equity | -186 295,79 | -108 989,03 | -250 354,32 | -282 645,29 | -251 879,21 | -210 488,20 |
| B. Liabilities and provisions for liabilities | 321 709,31 | 273 847,87 | 515 053,85 | 571 589,40 | 652 999,46 | 558 905,03 |
| I. Long-term liabilities | 0,00 | 0,00 | 413 587,61 | 461 701,58 | 468 331,19 | 376 706,69 |
| II. Short-term liabilities | 321 709,31 | 273 847,87 | 101 466,24 | 109 887,82 | 184 668,27 | 182 198,34 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.